Spero Therapeutics
SPRO
HK$18.05
Share price
-1.29%
Change (1 day)
60.52%
Change (1 year)
Categories
Earnings for Spero Therapeutics (SPRO)
Earnings in 2025 (TTM): -HK$0.57 Billion
According to Spero Therapeutics's latest financial reports the company's current earnings are HK$28.3 Million. In 2024 the company made an earning of -HK$0.57 Billion a decrease over its 2023 earnings that were of HK$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Spero Therapeutics from 2017 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -HK$0.57 Billion | -0.08% |
| 2024 | -HK$0.57 Billion | -360.42% |
| 2023 | HK$0.21 B | -163.53% |
| 2022 | -HK$0.35 Billion | -50.14% |
| 2021 | -HK$0.69 Billion | 11.06% |
| 2020 | -HK$0.63 Billion | 25.15% |
| 2019 | -HK$0.5 Billion | 47.68% |
| 2018 | -HK$0.34 Billion | 5.61% |
| 2017 | -HK$0.32 Billion |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Franklin Covey FC | HK$0.12 B | -122.04% | 🇺🇸 USA |
 IBM IBM | HK$46.16 B | -8,149.77% | 🇺🇸 USA |
 Thomson Reuters
TRI | HK$15.80 B | -2,855.35% | 🇨🇦 Canada |